课题基金 / 基金详情

Validation of Novel Strategy in Treatment Delivery and Anti-Tumour Effects in Human Glioblastoma

Validation of Novel Strategy in Treatment Delivery and Anti-Tumour Effects in Human Glioblastoma
人类胶质母细胞瘤治疗实施和抗肿瘤作用新策略的验证
批准号：
486090
负责人：
Sorge Alexandra J
金额：
$1.27万
依托单位：
University of Windsor (Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=486090&lang=en
关键词：
Biochemistry Brain Tumour Cancer Cell Biology Clinical Glioblastoma Interdisciplinary Nanoparticles Next Generation Therapy Temazolamide

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Glioblastoma (GBM) is the most common and aggressive brain tumour which continues to puzzle researchers as decades of efforts to find an effective therapy have proven to fail. Collaborative studies resulted in generation of particles of a microscopic size
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金